Developing novel therapeutics to treat ophthalmic diseases, with a focus on orphan and age-related retinal diseases

Glenn P. Sblendorio
President & CEO
Glenn P. Sblendorio
Abraham Scaria
Chief Scientific Officer
Amy Sheehan
Chief Human Resources Officer
David F. Carroll
Chief Financial Officer
Chris Simms
Chief Commercial Officer
Evelyn Harrison
Chief Clinical Operations Officer
Guangping Gao
Chief Strategist, Gene Therapy
Xiao - Ping Dai
Chief Technical Officer
Snehal Shah
Chief Regulatory Affairs & Pharmacovigilance
Dhaval Desai
Chief Development Officer
Kourous A. Rezaei
Senior Vice President and Chief Medical Officer
Todd D.C. Anderman
General Counsel & Corporate Secretary
Kathy Galante
Investor Relations

No teams yet!

No jobs yet!

No wires yet!

By clicking "Continue" or continuing to use our site, you acknowledge that you accept our Privacy Policy and Terms of Use. We also use cookies to provide you with the best possible experience on our website.